Topline Results from Alkeus Pharmaceuticals’ Study of Oral Gildeuretinol Demonstrate Significant Trend in Slowing GA Progression and Visual Function Improvement
23. Oktober 2024 09:00 ET
|
Alkeus Pharmaceuticals
Alkeus Pharmaceuticals, Inc., today announced that results from its study of gildeuretinol in geographic atrophy were presented at AAO 2024.
Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting
22. Oktober 2024 07:05 ET
|
Clearside Biomedical, Inc.
- CLS-AX Phase 3 Ready Based on Positive Phase 2b Topline Data in Wet AMD - - Differentiated Profile for CLS-AX Targeting Flexible Dosing Similar to a Biologic with the Potential Extended Duration of...
Alkeus Pharmaceuticals Announces Data Presentations at the American Academy of Ophthalmology (AAO) 2024 Annual Meeting, October 18-21 in Chicago
17. Oktober 2024 08:29 ET
|
Alkeus Pharmaceuticals
Results from Study of Oral Gildeuretinol for Geographic Atrophy Secondary to Age-Related Macular Degeneration to be Presented as Late-Breaker During Retina Subspecialty Day Positive Data from TEASE...
Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting
07. November 2023 16:20 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...
Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual Meeting
02. November 2023 07:05 ET
|
Clearside Biomedical, Inc.
Clearside Biomedical announced that multiple oral & poster presentations will be delivered at the American Academy of Ophthalmology (AAO) 2023 Annual Mtg.
EyeMD EMR Healthcare Systems Inc. Announces the Release of Axon Patient Engagement at AAO 2023
31. Oktober 2023 09:55 ET
|
EyeMD EMR Healthcare Systems, Inc.
EyeMD EMR Healthcare Systems Inc. Announces the Release of Axon Patient Engagement at AAO 2023
Nextech to Highlight Ophthalmology Solution Innovations at AAO Conference
30. Oktober 2023 10:42 ET
|
Nextech Systems, Inc.
Nextech will showcase transformative innovations to its ophthalmology industry-leading software at the AAO 2023 conference from Nov. 3-6.
Iantrek reports two upcoming American Academy of Ophthalmology presentations of its breakthrough glaucoma surgical technologies, including 1-year results of a novel supraciliary outflow micro-interventional procedure
16. Oktober 2023 08:00 ET
|
Iantrek, Inc.
Biotech startup to present 12 month data for novel Glaucoma treatment at AAO.
Positive Data Presentations at AAO Annual Meeting Demonstrate Utility and Versatility of Clearside Biomedical’s Proprietary Suprachoroidal Space Platform
04. Oktober 2022 07:05 ET
|
Clearside Biomedical, Inc.
- Favorable Safety Profiles and Encouraging Efficacy Data Reported in Clinical Trials in the Suprachoroidal Space (SCS®) Across Multiple Therapeutic Areas using Clearside’s SCS Microinjector® - - SCS...
eSight™ Assistive Device for Visually Impaired Available for Demonstrations at AAO
20. September 2022 09:00 ET
|
eSight
CHICAGO, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Leading vision enhancement platform, eSight, is holding demonstrations of its current medical device model, eSight 4, at the American Academy of...